Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NMR-based screening technologies.

Murray Coles1, Markus Heller, Horst Kessler

  • 1Institut für Organische Chemie und Biochemie, Technische Universität München Lichtenbergstrasse 4, 85747, Garching, Germany.

Drug Discovery Today
|August 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Complementarity-Based Approach to De Novo Binder Design.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Discovery of synthetic small molecules targeting the central regulator of <i>Salmonella</i> pathogenicity.

Science advances·2025
Same author

Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands.

Journal of medicinal chemistry·2025
Same author

Importance of integrin transmembrane helical interactions for antagonistic versus agonistic ligand behavior: Consequences for medical applications.

Bioorganic chemistry·2025
Same author

Covalent Fragments Acting as Tyrosine Mimics for Mutant p53-Y220C Rescue by Nucleophilic Aromatic Substitution.

ACS pharmacology & translational science·2024
Same author

Hypoxia-driven heterogeneous expression of α5 integrin in glioblastoma stem cells is linked to HIF-2α.

Biochimica et biophysica acta. Molecular basis of disease·2024
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
Same journal

A20 as a novel immunoregulatory target for neuroinflammation.

Drug discovery today·2026
See all related articles

Nuclear Magnetic Resonance (NMR) ligand screening is a vital tool in drug discovery. Recent advancements enhance its capabilities and integration with other methods for industrial drug research.

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Structural Biology

Background:

  • Nuclear Magnetic Resonance (NMR) based ligand screening has become a significant field.
  • Recent advancements in NMR methodology and hardware have expanded its applications.
  • NMR screening is increasingly important in industrial drug research.

Purpose of the Study:

  • To provide an overview of novel NMR screening methods and their applications.
  • To discuss the synergistic use of NMR screening with other screening techniques.

Main Methods:

  • Review of recent literature on NMR-based ligand screening.
  • Analysis of new NMR techniques and hardware.
  • Examination of integrated screening strategies.

Related Experiment Videos

Main Results:

  • NMR ligand screening has evolved significantly with improved techniques.
  • Practical limitations in NMR screening have been reduced.
  • NMR screening is effectively integrated with other screening platforms.

Conclusions:

  • NMR-based ligand screening is a mature and expanding field.
  • Advancements continue to enhance the utility of NMR screening in drug discovery.
  • Collaborative approaches using NMR and other techniques are crucial for industrial drug research.